Clinical Trial Update: Biomarkers In Seizure To Predict Recurrence and Severe Outcomes

View source ↗

Summary

Completed clinical trial evaluating biomarkers S-100b and copeptin to predict seizure recurrence and severe outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: Bistro Study Group | Conditions: Seizures, S-100b Protein | Status: COMPLETED